SIGANasdaqPharmaceutical PreparationsFiscal year ends December 31
SIGA TECHNOLOGIES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.14−0.03 (-0.95%)
Close on Oct 19, 2026
- Market cap
- $225.72M
- P/E (TTM)
- –
- Dividend yield
- 19.11%
Share price
−$5.16 (−62.17%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
SIGA TECHNOLOGIES INC saw revenue fall 70.1% to $53.66M over the twelve months to Jun 30, 2026. Operating income fell 111.0% to -$11.14M, moving the operating margin from 56.3% to -20.8%.
Revenue
$53.66M
-70.1% vs. a year earlier
Operating income
-$11.14M
-111.0% vs. a year earlier
EPS, diluted
-$0.05
-104.4% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $225.72M
- P/E ratio
- –
- Price to sales
- 4.21
- Price to book
- 1.37
- Dividend yield
- 19.11%
- Free cash flow yield
- –
Fundamentals
- Revenue
- $53.66M
- Net income
- -$2.79M
- EPS, diluted
- -$0.05
- Book value per share
- $2.30
- Diluted shares
- 72M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$53.66M-70.1% YoY
Gross profit
$29.17M-78.9% YoY
Operating income
-$11.14M-111.0% YoY
Net income
-$2.79M-103.4% YoY
EPS, diluted
-$0.05-104.4% YoY
Free cash flow
–
Reported periodTrailing twelve months